Pectoserratus Block + Interscalene Block for Shoulder Surgery
Trial Summary
What is the purpose of this trial?
The use of ISB in patients undergoing total shoulder arthroplasty (TSA) is the gold standard and results in significantly reduced pain scores and opioid use. However, patients still have pain and the majority require opioids postoperatively as the interscalene block (ISB) doesn't cover all of the dermatomes impacted during TSA. A pectoserratus block typically provides coverage to additional dermatomes that are impacted during TSA. Currently ISB is performed for every patient and perform a pectoserratus block to a portion of our patients undergoing TSA. The purpose of the study is to determine if the addition of the pectoserratus block to the ISB will results in improvement in pain control and decrease in opioid use, among patients undergoing TSA. This is a randomized prospective controlled trial. All patients undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty aged 18-85 will be considered eligible for the study. Participants will be randomized to one of 2 treatment groups. Group 1 will receive an ultrasound guided pectoserratus block with 25 mL of 0.25% bupivacaine. Group 2 will be the control and receive an ultrasound guided pectoserratus block with 25 mL of saline. The drug will be administered by the anesthesiologist in-charge of the participant's care or an anesthesiologist who is a part of the study team.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude patients who are currently using opioids or have chronic pain.
What data supports the effectiveness of the treatment Pectoserratus Block + Interscalene Block for Shoulder Surgery?
Is the Pectoserratus Block + Interscalene Block for shoulder surgery safe?
How does the interscalene block treatment differ from other treatments for shoulder surgery?
The interscalene block (ISB) is a regional anesthesia technique that specifically targets the nerves in the neck to provide pain relief for shoulder surgeries, offering an alternative to general anesthesia or intravenous sedatives. It is often combined with a serratus plane block to enhance anesthesia quality, making it unique in its ability to provide targeted pain relief and muscle relaxation without the need for additional analgesia.23101112
Research Team
Jacob Hutchins, MD, MHA
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for patients aged 18-85 undergoing total shoulder replacement surgery. It's suitable for those who can receive an ultrasound-guided block as part of their pain management.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a pectoserratus block with bupivacaine or saline during total shoulder arthroplasty
Postoperative Monitoring
Participants are monitored for pain and opioid use within the first 48 hours post-operation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including hospital length of stay and functional pain score
Treatment Details
Interventions
- Interscalene Block
- Pectoserratus Block
Interscalene Block is already approved in United States, European Union, Canada for the following indications:
- Shoulder surgery
- Total shoulder arthroplasty
- Reverse total shoulder arthroplasty
- Shoulder surgery
- Total shoulder arthroplasty
- Reverse total shoulder arthroplasty
- Shoulder surgery
- Total shoulder arthroplasty
- Reverse total shoulder arthroplasty
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor